Mohs显微描记手术与扩大局部切除治疗原位黑色素瘤的结局比较
该回顾性队列研究纳入1978年至2013年在一家学术三级转诊中心接受Mohs显微描记手术(MMS)或扩大局部切除(WLE)的662例原位黑色素瘤(MIS)患者,随访至2015年。结果显示MMS组与WLE组在复发率、总生存率和黑色素瘤特异性生存率上均无显著差异。
要点
- 两组总生存率和黑色素瘤特异性死亡率无显著差异。
- MMS更常用于面部、头皮和颈部等特殊部位。
核心结论
- MMS与WLE治疗MIS在复发率、总生存率和黑色素瘤特异性生存率上无显著差异。
研究设计与样本
- 回顾性队列研究,纳入662例MIS患者,MMS组277例,WLE组385例,随访至2015年。
关键数值与推荐
- MMS组平均年龄64.0岁(SD 13.1),男性62.1%;WLE组平均年龄58.5岁(SD 15.6),男性54.8%。
- MMS组中位随访8.6年(范围0.2-37年)。
临床怎么用
- 对于MIS,MMS可作为与WLE相当的选项,尤其在面部等需保留组织的部位。
局限性
- 回顾性设计,两组诊断年份和年龄存在差异,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Melanoma in situ (MIS) is increasing in incidence, and expert consensus opinion recommends surgical excision for therapeutic management. Currently, wide local excision (WLE) is the standard of care. However, Mohs micrographic surgery (MMS) is now used to treat a growing subset of individuals with MIS. During MMS, unlike WLE, the entire cutaneous surgical margin is evaluated intraoperatively for tumor cells. OBJECTIVE: To assess the outcomes of patients with MIS treated with MMS compared with those treated with WLE. DESIGN, SETTING, AND PARTICIPANTS: Retrospective review of a prospective database. The study cohort consisted of 662 patients with MIS treated with MMS or WLE per standard of care in dermatology and surgery (general surgery, otolaryngology, plastics, oculoplastics, surgical oncology) at an academic tertiary care referral center from January 1, 1978, to December 31, 2013, with follow-up through 2015. EXPOSURE: Mohs micrographic surgery or WLE. MAIN OUTCOMES AND MEASURES: Recurrence, overall survival, and melanoma-specific survival. RESULTS: There were 277 patients treated with MMS (mean [SD] age, 64.0 [13.1] years; 62.1% male) and 385 treated with WLE (mean [SD] age, 58.5 [15.6] years; P < .001 for age; 54.8% male). Median follow-up was 8.6 (range, 0.2-37) years. Compared with WLE, MMS was used more frequently on the face (222 [80.2%] vs 141 [36.7%]) and scalp and neck (23 [8.3%] vs 26 [6.8%]; P < .001). The median (range) year of diagnosis was 2008 (1986-2013) for the MMS group vs 2003 (1978-2013) for the WLE group (P < .001). Overall recurrence rates were 5 (1.8%) in the MMS group and 22 (5.7%) in the WLE group (P = .07). Mean (SD) time to recurrence after MMS was 3.91 (4.4) years, and after WLE, 4.45 (2.7) years (P = .73). The 5-year recurrence rate was 1.1% in the MMS group and 4.1% in the WLE group (P = .07). For WLE-treated tumors, the surgical margin taken was greater for tumors that recurred compared with tumors that did not recur (P = .003). Five-year overall survival for MMS was 92% and for WLE was 94% (P = .28). Melanoma-specific mortality for the MMS group was 2 vs 13 patients for the WLE group, with mean (SD) survival of 6.5 (4.8) and 6.1 (0.8) years, respectively (P = .77). CONCLUSIONS AND RELEVANCE: No significant differences were found in the recurrence rate, overall survival, or melanoma-specific survival of patients with MIS treated with MMS compared with WLE.
引用
- Nosrati A, Berliner JG, Goel S, et al. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision. JAMA Dermatol. 2017. PMID: 28241261. doi:10.1001/jamadermatol.2016.6138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。